{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:31:57Z","timestamp":1793039517820,"version":"4.5.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T00:00:00Z","timestamp":1525651200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00984","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T00:14:59Z","timestamp":1525652099000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":77,"title":["Human \u03b3\u03b4 T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias"],"prefix":"10.3389","volume":"9","author":[{"given":"Vito","family":"Pistoia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tumino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Veneziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1002\/eji.201343759","article-title":"Functional development of gammadelta T cells","volume":"43","author":"Prinz","year":"2013","journal-title":"Eur J Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/BF02935618","article-title":"TCR gamma delta cells: mysterious cells of the immune system","volume":"13","author":"Sciammas","year":"1994","journal-title":"Immunol Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12967-017-1378-2","article-title":"Gamma-delta (gammadelta) T cells: friend or foe in cancer development?","volume":"16","author":"Zhao","year":"2018","journal-title":"J Transl Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cellimm.2015.04.008","article-title":"Human gamma delta T cells: evolution and ligand recognition","volume":"296","author":"Adams","year":"2015","journal-title":"Cell Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3324\/haematol.2010.029520","article-title":"Gammadelta T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody","volume":"96","author":"Braza","year":"2011","journal-title":"Haematologica"},{"key":"B6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1600-065X.2006.00468.x","article-title":"Self\/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?","volume":"215","author":"Thedrez","year":"2007","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nri797","article-title":"Gammadelta T cells: functional plasticity and heterogeneity","volume":"2","author":"Carding","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nri2781","article-title":"Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity","volume":"10","author":"Bonneville","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/cmi.2016.55","article-title":"Human gammadeltaT-cell subsets and their involvement in tumor immunity","volume":"14","author":"Wu","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1084\/jem.169.5.1847","article-title":"Human TCR-gamma+\/delta+, CD8+ T lymphocytes recognize tetanus toxoid in an MHC-restricted fashion","volume":"169","author":"Kozbor","year":"1989","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/smim.1993.1006","article-title":"Gamma delta T cell reactivity towards bacterial superantigens","volume":"5","author":"Rust","year":"1993","journal-title":"Semin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","article-title":"Six-of-the-best: unique contributions of gammadelta T cells to immunology","volume":"13","author":"Vantourout","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000024353","article-title":"Antigen recognition by human gammadelta T lymphocytes","volume":"122","author":"Kabelitz","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","article-title":"Gammadelta T cells: first line of defense and beyond","volume":"32","author":"Chien","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e953410","DOI":"10.4161\/21624011.2014.953410","article-title":"Stress-related and homeostatic cytokines regulate Vgamma9Vdelta2 T-cell surveillance of mevalonate metabolism","volume":"3","author":"Gruenbacher","year":"2014","journal-title":"Oncoimmunology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/375155a0","article-title":"Natural and synthetic non-peptide antigens recognized by human gamma delta T cells","volume":"375","author":"Tanaka","year":"1995","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1084\/jem.20021500","article-title":"Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells","volume":"197","author":"Gober","year":"2003","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"8118","DOI":"10.4049\/jimmunol.0900101","article-title":"Reduced expression of the mevalonate pathway enzyme farnesyl pyrophosphate synthase unveils recognition of tumor cells by Vgamma9Vdelta2 T cells","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-2141.2008.07435.x","article-title":"Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP\/DMAPP","volume":"144","author":"Roelofs","year":"2009","journal-title":"Br J Haematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.4049\/jimmunol.1002697","article-title":"Indirect stimulation of human Vgamma2Vdelta2 T cells through alterations in isoprenoid metabolism","volume":"187","author":"Wang","year":"2011","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/ni.2665","article-title":"Butyrophilin 3A1 binds phosphorylated antigens and stimulates human gammadelta T cells","volume":"14","author":"Vavassori","year":"2013","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.0810059106","article-title":"Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses","volume":"106","author":"Brandes","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.exphem.2009.04.008","article-title":"Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma","volume":"37","author":"Abe","year":"2009","journal-title":"Exp Hematol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/CJI.0b013e318245bb1e","article-title":"Tumor-promoting versus tumor-antagonizing roles of gammadelta T cells in cancer immunotherapy: results from a prospective phase I\/II trial","volume":"35","author":"Kunzmann","year":"2012","journal-title":"J Immunother"},{"key":"B25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1182\/blood-2002-12-3665","article-title":"Gammadelta T cells for immune therapy of patients with lymphoid malignancies","volume":"102","author":"Wilhelm","year":"2003","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.4161\/onci.21512","article-title":"Immunotherapy of acute myeloid leukemia based on gammadelta T cells","volume":"1","author":"Gertner-Dardenne","year":"2012","journal-title":"Oncoimmunology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00262-006-0199-6","article-title":"Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study","volume":"56","author":"Kobayashi","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00262-008-0491-8","article-title":"Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma","volume":"57","author":"Bennouna","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00262-010-0879-0","article-title":"Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors","volume":"59","author":"Bennouna","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.ejcts.2009.11.051","article-title":"A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous gammadelta T cells","volume":"37","author":"Nakajima","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/CJI.0b013e318207ecfb","article-title":"Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded gammadeltaTcells: a phase I clinical study","volume":"34","author":"Sakamoto","year":"2011","journal-title":"J Immunother"},{"key":"B32","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/bjc.2011.293","article-title":"Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours","volume":"105","author":"Nicol","year":"2011","journal-title":"Br J Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.it.2017.06.004","article-title":"The ambiguous role of gammadelta T lymphocytes in antitumor immunity","volume":"38","author":"Chitadze","year":"2017","journal-title":"Trends Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nri3904","article-title":"Gammadelta T cells in cancer","volume":"15","author":"Silva-Santos","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1182\/blood-2008-12-196287","article-title":"The NKG2D ligand ULBP4 binds to TCRgamma9\/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D","volume":"114","author":"Kong","year":"2009","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/eji.201242531","article-title":"The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vdelta1 TCR","volume":"42","author":"Bai","year":"2012","journal-title":"Eur J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1073\/pnas.1015433108","article-title":"Crystal structure of a gammadelta T-cell receptor specific for the human MHC class I homolog MICA","volume":"108","author":"Xu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B38","doi-asserted-by":"publisher","first-page":"26448","DOI":"10.1074\/jbc.M113.484600","article-title":"Vav1-phospholipase C-gamma1 (Vav1-PLC-gamma1) pathway initiated by T cell antigen receptor (TCRgammadelta) activation is required to overcome inhibition by ubiquitin ligase Cbl-b during gammadeltaT cell cytotoxicity","volume":"288","author":"Yin","year":"2013","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/eji.200838409","article-title":"DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells","volume":"39","author":"Toutirais","year":"2009","journal-title":"Eur J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2249.2006.03078.x","article-title":"Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells","volume":"144","author":"von Lilienfeld-Toal","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1172\/JCI30989","article-title":"Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease","volume":"118","author":"Bhagat","year":"2008","journal-title":"J Clin Invest"},{"key":"B42","first-page":"249","article-title":"TCR gamma\/delta positive lymphocytes after allogeneic bone marrow transplantation","volume":"10","author":"Viale","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"B43","first-page":"741","article-title":"Transition of T cell receptor gamma\/delta expressing double negative (CD4-\/CD8-) lymphocytes after allogeneic bone marrow transplantation","volume":"14","author":"Yabe","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"B44","first-page":"243","article-title":"Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors","volume":"17","author":"Cela","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"B45","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","article-title":"Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation","volume":"39","author":"Godder","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"B46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/0032472031000141295","article-title":"Influence of T cell depletion method on circulating gammadelta T cell reconstitution and potential role in the graft-versus-leukemia effect","volume":"1","author":"Lamb","year":"1999","journal-title":"Cytotherapy"},{"key":"B47","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1089\/scd.1.1996.5.503","article-title":"Increased frequency of TCR gamma delta + T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia","volume":"5","author":"Lamb","year":"1996","journal-title":"J Hematother"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1182\/blood-2008-06-164103","article-title":"Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity","volume":"113","author":"Pende","year":"2009","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bbmt.2014.09.027","article-title":"Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia","volume":"21","author":"Perko","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B51","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/sj.bmt.1702478","article-title":"Reconstitution of gammadelta T cell repertoire diversity after human allogeneic hematopoietic cell transplantation and the role of peripheral expansion of mature T cell population in the graft","volume":"26","author":"Hirokawa","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"B52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ni.3686","article-title":"Human gammadelta T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection","volume":"18","author":"Ravens","year":"2017","journal-title":"Nat Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"key":"B54","first-page":"69","article-title":"T-cell depletion in allogeneic bone marrow transplantation for acute leukaemias","volume":"4","author":"Aversa","year":"1989","journal-title":"Bone Marrow Transplant"},{"key":"B55","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1182\/blood-2010-08-264085","article-title":"Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation","volume":"117","author":"Moretta","year":"2011","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.molimm.2004.07.028","article-title":"PVR (CD155) and nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis","volume":"42","author":"Pende","year":"2005","journal-title":"Mol Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1200\/JCO.2012.47.4007","article-title":"Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation","volume":"31","author":"Bari","year":"2013","journal-title":"J Clin Oncol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1182\/blood-2004-10-4113","article-title":"NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect","volume":"105","author":"Nguyen","year":"2005","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1182\/blood-2007-07-103325","article-title":"Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation","volume":"112","author":"Vago","year":"2008","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.imlet.2013.09.027","article-title":"Negative depletion of alpha\/beta+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation","volume":"155","author":"Locatelli","year":"2013","journal-title":"Immunol Lett"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jcyt.2013.05.014","article-title":"Depletion of T-cell receptor alpha\/beta and CD19 positive cells from apheresis products with the CliniMACS device","volume":"15","author":"Schumm","year":"2013","journal-title":"Cytotherapy"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1182\/blood-2014-09-599423","article-title":"Gammadelta T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-alphabeta+\/CD19+ lymphocytes","volume":"125","author":"Airoldi","year":"2015","journal-title":"Blood"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.bbmt.2015.07.008","article-title":"Single-center experience of unrelated and haploidentical stem cell transplantation with TCRalphabeta and CD19 depletion in children with primary immunodeficiency syndromes","volume":"21","author":"Balashov","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B65","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of alphabeta+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after alphabeta T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fimmu.2015.00003","article-title":"Direct and indirect effects of cytomegalovirus-induced gammadelta T cells after kidney transplantation","volume":"6","author":"Couzi","year":"2015","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/eji.200525983","article-title":"Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vgamma9Vdelta2 naive, memory and effector T cell subsets","volume":"35","author":"Caccamo","year":"2005","journal-title":"Eur J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1084\/jem.20030235","article-title":"Differentiation of effector\/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites","volume":"198","author":"Dieli","year":"2003","journal-title":"J Exp Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ni.2394","article-title":"Cytomegalovirus and tumor stress surveillance by binding of a human gammadelta T cell antigen receptor to endothelial protein C receptor","volume":"13","author":"Willcox","year":"2012","journal-title":"Nat Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1182\/blood-2010-01-255166","article-title":"The role of Vdelta2-negative gammadelta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation","volume":"116","author":"Knight","year":"2010","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e23974","DOI":"10.4161\/onci.23974","article-title":"Multifunctional gammadelta T cells and their receptors for targeted anticancer immunotherapy","volume":"2","author":"Scheper","year":"2013","journal-title":"Oncoimmunology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e1216291","DOI":"10.1080\/2162402X.2016.1216291","article-title":"Zoledronic acid boosts gammadelta T-cell activity in children receiving alphabeta(+) T and CD19(+) cell-depleted grafts from an HLA-haplo-identical donor","volume":"6","author":"Bertaina","year":"2017","journal-title":"Oncoimmunology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00984\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T00:15:04Z","timestamp":1525652104000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00984\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,7]]},"references-count":74,"alternative-id":["10.3389\/fimmu.2018.00984"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00984","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,7]]},"article-number":"984"}}